Pharmaceutical Business review

Sucampo Pharmaceuticals names new vice president

For the past 11 years, Ms Santis served as director of investor relations and corporate communications at Human Genome Sciences.

Ms Santis holds an MBA in marketing management from Pace University’s Lubin Graduate School of Business, in White Plains, New York, and a BA in english literature from Molloy College, in Rockville Centre, New York.

Ryuji Ueno, chairman and CEO of Sucampo, said: “I am very pleased to welcome Kate to Sucampo. We look forward to utilizing her extensive expertise in the life sciences industry as we shape our investor relations and corporate communications’s program.”